Dimethylmethoxy chromanyl palmitate is a peptide (trade name Chromabright) that has limited but intriguing research on how it interrupts the pathway for melanin (skin pigment) synthesis. There’s not much research, but it does appear promising (Source: www.healthestatejournal.com/Print.aspx?Story=4710).